Ecker + Ecker

What Ecker + Ecker does

Ecker + Ecker GmbH is a Hamburg-based, privately held management consultancy founded in 2009 that specializes exclusively in Market Access, Pricing, and Reimbursement advisory for the German and broader European healthcare sector. The firm serves pharmaceutical, medical device, and diagnostics manufacturers across the full product lifecycle, with core offerings centered on early benefit assessment under AMNOG (Frühe Nutzenbewertung and Erstattungsbetragsverhandlung), European Health Technology Assessment (EU-HTA), fixed-benefit analysis (Festbeträge and Herstellerrabatte), statistical re-analysis of clinical studies for HTA, DiGA (digital health applications), and modular Pricing & Reimbursement optimization. Engagement is delivered by an interdisciplinary team of biologists, pharmacists, health economists, business economists, and statisticians, supported by proprietary tools including the Ecker + Ecker Festbetragsrechner software and interactive reimbursement simulation instruments, with statistical workflows executed in SAS and R.

The firm operates on a project-based, quote-based consulting model, selling directly to enterprise clients (pharmaceutical and medical device manufacturers) primarily in Germany, with extension into Austria, Switzerland, and other EU markets through a curated European partner network used for EU-HTA dossiers. Ecker + Ecker is affiliated with the athagoras consulting network, though it operates as an independent GmbH. Leadership comprises founders Dr. Christof Ecker and Dr. Thomas Ecker alongside managing director Janine Leismann, with the company headquartered at Warburgstr. 50, Hamburg.

The firm monetizes expertise through fee-for-service consulting engagements rather than software licenses or subscription products, with no publicly disclosed pricing. Its commercialization is anchored on technical thought leadership via a publications library, LinkedIn Fach-Posts, and direct enterprise relationships built over 15 years. No external funding, parent company ownership beyond the athagoras affiliation, M&A activity, or public revenue figures are present in the source material.

Name

Ecker + Ecker

Legal name

Ecker + Ecker GmbH

Website

https://ecker-ecker.de

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

101–250 employees

Short description

Ecker + Ecker GmbH is a Hamburg-based management consultancy that advises pharmaceutical, medical device, and diagnostics manufacturers on Market Access, Pricing, and Reimbursement in Germany and the EU, specializing in AMNOG early benefit assessment, EU-HTA dossiers, fixed-benefit modeling, and clinical study statistics.

Ownership category

akta.pro rank

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Consulting Services: Ecker + Ecker provides specialized consulting services for Market Access, Pricing, and Reimbursement to pharmaceutical and medical device manufacturers. Services include early benefit assessment (AMNOG), EU-HTA, pricing & reimbursement strategy, fixed benefit rates expertise, and statistical analysis for Market Access.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Ecker + Ecker GmbH is a Hamburg-based management consultancy providing specialized Market Access, Pricing, and Reimbursement advisory services to pharmaceutical, medical device, and diagnostics manufacturers operating in Germany and the European Union. Core offerings include early benefit assessment (AMNOG) strategy, dossier preparation, reimbursement price negotiation, arbitration support, EU-HTA consulting via a European partner network, fixed-rate and manufacturer rebate analysis, statistical evaluation of clinical studies for Market Access, and digital health application (DiGA) reimbursement advisory. The firm also offers the proprietary Ecker + Ecker Festbetragsrechner software for fixed-rate group price prediction.

Product overview

Ecker + Ecker GmbH is a specialized consulting firm providing integrated Market Access and Pricing services for pharmaceutical manufacturers and medical device companies in Germany. The company operates as a unified service offering rather than a modular platform, delivering expert consulting across the complete product lifecycle. Core services include early benefit assessment (Frühe Nutzenbewertung) and AMNOG price negotiations, European HTA (EU-HTA) consulting, fixed-rate and manufacturer rebate analysis (Festbeträge), statistical analyses for Market Access, and Pricing & Reimbursement optimization. The company also offers specialized tools including the Ecker + Ecker Festbetragsrechner (fixed-rate calculator software) for pharmaceutical manufacturers. Additional services cover digital health applications (DiGA), indirect comparisons, meta-analyses, and study re-evaluations following G-BA and IQWiG methodology.

Differentiator

Problem solved

Functional benefit

Products and services

• Frühe Nutzenbewertung und Erstattungsbetragsverhandlung (Early Benefit Assessment and Reimbursement Price Negotiation)

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• athagorasparent companyOthersEcker + Ecker is part of athagoras, a consulting network. The company logo indicates it is 'Part of athagoras'. This appears to be a corporate parent or affiliated network relationship.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Simon-Kucher & Partners: Global strategy consultancy widely regarded as the leading pricing and Market Access specialist for the life-sciences industry. Directly comparable to Ecker + Ecker in pharma pricing, reimbursement and HTA advisory, with a much larger international footprint.
• Charles River Associates: Economic and financial consulting firm with a Life Sciences practice covering pricing, market access, HEOR and HTA strategy. Competes with Ecker + Ecker on quantitative, evidence-based market access engagements for pharma and medical device clients.
• ZS Associates: Global consulting firm with a large pharma and biotech practice covering commercial strategy, launch, pricing and market access. Comparable in serving enterprise pharma manufacturers on launch readiness and access strategy, with broader scale.
• PharmaLex (Cencora): Regulatory and market access consultancy now part of Cencora (formerly AmerisourceBergen), serving pharma manufacturers on registration, HTA and reimbursement. Directly comparable on European regulatory and market access advisory.

Broad incumbents

• Kearney: Global management consulting firm with a Health and Life Sciences practice covering commercial strategy, market access and pricing. Comparable as a broader-incumbent alternative for pharma manufacturers seeking integrated advisory support.
• Boston Consulting Group: Global strategy consulting firm with deep pharma and biotech practice covering pricing, market access and launch. Comparable at the high end of the market where BCG's broader transformation mandate often bundles access work.
• Roland Berger: German-headquartered global strategy consultancy with a strong healthcare and pharma practice. Most directly comparable among the incumbents due to German home-market presence and overlapping pharma client base.
• McKinsey & Company: Global strategy consulting firm with a large Pharmaceuticals & Medical Products practice that bundles Market Access into broader transformation engagements. Competes on the largest enterprise accounts where buyers seek single accountability.
• IQVIA: Largest healthcare data, analytics and consulting franchise, with extensive Market Access, HEOR and RWE capabilities serving global pharma. Competes on enterprise engagements that combine data assets with advisory services.
• Deloitte (Life Sciences Practice): Big-4 firm with a global Life Sciences practice covering Market Access, pricing, HEOR and regulatory strategy. Competes on bundled enterprise mandates and cross-functional pharma transformations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ecker-ecker

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ecker + Ecker